Prospective risk stratification in renal transplant candidates for cardiac death

A. Le, R. Wilson, K. Douek, L. Pulliam, D. Tolzman, Douglas Norman, John Barry, W. Bennett

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

In previous studies to predict future cardiac death of patients undergoing evaluation for renal transplantation, noninvasive or invasive testing of all, or nearly all, patients has been used. In an attempt to decrease the cost of cardiac risk assessment, we prospectively used a two-tiered cardiac risk assessment algorithm on 189 consecutive patients referred for renal transplant evaluation. First, patients were stratified by clinical characteristics of age ≥50 years, history of angina, insulin- dependent diabetes, congestive heart failure, or abnormal electrocardiogram (excluding left ventricular hypertrophy). Patients having none of these risk factors (n = 94) were considered at low risk for cardiac events and underwent no further cardiac evaluation. Patients with one or more of the cardiac risk factors (n = 95) were considered to be in a high-risk group and were required to undergo further evaluation with thallium myocardial scintigraphy. Follow-up of patients was for 46 ± 16 months. Cardiac mortality was significantly higher in the clinical high-risk group compared with the clinical low-risk group (17% v 1%, respectively; P <0.001). Further cardiac risk stratification was evident by thallium myocardial scintigraphy. Patients with reversible thallium defects had significantly higher cardiac mortality rates than patients with no thallium defects (23% v 5%, respectively; P <0.05). Fixed thallium defects also had predictive value for cardiac mortality (29%,; P <0.05), but deaths in this fixed defect group tended to occur later in the follow-up period. The initial clinical stratification obviated the need for further noninvasive or invasive testing in nearly half of the renal transplant candidates. Thallium myocardial scintigraphy effectively identified those patients at the highest cardiac risk. In conclusion, this prospectively applied, two-tiered cardiac stratification algorithm effectively may be a cost-effective method for detecting renal transplant patients at high risk for cardiac mortality, even in long-term follow-up.

Original languageEnglish (US)
Pages (from-to)65-71
Number of pages7
JournalAmerican Journal of Kidney Diseases
Volume24
Issue number1
StatePublished - 1994

Fingerprint

Transplants
Kidney
Thallium
Myocardial Perfusion Imaging
Mortality
Costs and Cost Analysis
Left Ventricular Hypertrophy
Kidney Transplantation
Electrocardiography
Heart Failure
Insulin

ASJC Scopus subject areas

  • Nephrology

Cite this

Le, A., Wilson, R., Douek, K., Pulliam, L., Tolzman, D., Norman, D., ... Bennett, W. (1994). Prospective risk stratification in renal transplant candidates for cardiac death. American Journal of Kidney Diseases, 24(1), 65-71.

Prospective risk stratification in renal transplant candidates for cardiac death. / Le, A.; Wilson, R.; Douek, K.; Pulliam, L.; Tolzman, D.; Norman, Douglas; Barry, John; Bennett, W.

In: American Journal of Kidney Diseases, Vol. 24, No. 1, 1994, p. 65-71.

Research output: Contribution to journalArticle

Le, A, Wilson, R, Douek, K, Pulliam, L, Tolzman, D, Norman, D, Barry, J & Bennett, W 1994, 'Prospective risk stratification in renal transplant candidates for cardiac death', American Journal of Kidney Diseases, vol. 24, no. 1, pp. 65-71.
Le, A. ; Wilson, R. ; Douek, K. ; Pulliam, L. ; Tolzman, D. ; Norman, Douglas ; Barry, John ; Bennett, W. / Prospective risk stratification in renal transplant candidates for cardiac death. In: American Journal of Kidney Diseases. 1994 ; Vol. 24, No. 1. pp. 65-71.
@article{e1c6e21931a44d9dace531761b70c061,
title = "Prospective risk stratification in renal transplant candidates for cardiac death",
abstract = "In previous studies to predict future cardiac death of patients undergoing evaluation for renal transplantation, noninvasive or invasive testing of all, or nearly all, patients has been used. In an attempt to decrease the cost of cardiac risk assessment, we prospectively used a two-tiered cardiac risk assessment algorithm on 189 consecutive patients referred for renal transplant evaluation. First, patients were stratified by clinical characteristics of age ≥50 years, history of angina, insulin- dependent diabetes, congestive heart failure, or abnormal electrocardiogram (excluding left ventricular hypertrophy). Patients having none of these risk factors (n = 94) were considered at low risk for cardiac events and underwent no further cardiac evaluation. Patients with one or more of the cardiac risk factors (n = 95) were considered to be in a high-risk group and were required to undergo further evaluation with thallium myocardial scintigraphy. Follow-up of patients was for 46 ± 16 months. Cardiac mortality was significantly higher in the clinical high-risk group compared with the clinical low-risk group (17{\%} v 1{\%}, respectively; P <0.001). Further cardiac risk stratification was evident by thallium myocardial scintigraphy. Patients with reversible thallium defects had significantly higher cardiac mortality rates than patients with no thallium defects (23{\%} v 5{\%}, respectively; P <0.05). Fixed thallium defects also had predictive value for cardiac mortality (29{\%},; P <0.05), but deaths in this fixed defect group tended to occur later in the follow-up period. The initial clinical stratification obviated the need for further noninvasive or invasive testing in nearly half of the renal transplant candidates. Thallium myocardial scintigraphy effectively identified those patients at the highest cardiac risk. In conclusion, this prospectively applied, two-tiered cardiac stratification algorithm effectively may be a cost-effective method for detecting renal transplant patients at high risk for cardiac mortality, even in long-term follow-up.",
author = "A. Le and R. Wilson and K. Douek and L. Pulliam and D. Tolzman and Douglas Norman and John Barry and W. Bennett",
year = "1994",
language = "English (US)",
volume = "24",
pages = "65--71",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Prospective risk stratification in renal transplant candidates for cardiac death

AU - Le, A.

AU - Wilson, R.

AU - Douek, K.

AU - Pulliam, L.

AU - Tolzman, D.

AU - Norman, Douglas

AU - Barry, John

AU - Bennett, W.

PY - 1994

Y1 - 1994

N2 - In previous studies to predict future cardiac death of patients undergoing evaluation for renal transplantation, noninvasive or invasive testing of all, or nearly all, patients has been used. In an attempt to decrease the cost of cardiac risk assessment, we prospectively used a two-tiered cardiac risk assessment algorithm on 189 consecutive patients referred for renal transplant evaluation. First, patients were stratified by clinical characteristics of age ≥50 years, history of angina, insulin- dependent diabetes, congestive heart failure, or abnormal electrocardiogram (excluding left ventricular hypertrophy). Patients having none of these risk factors (n = 94) were considered at low risk for cardiac events and underwent no further cardiac evaluation. Patients with one or more of the cardiac risk factors (n = 95) were considered to be in a high-risk group and were required to undergo further evaluation with thallium myocardial scintigraphy. Follow-up of patients was for 46 ± 16 months. Cardiac mortality was significantly higher in the clinical high-risk group compared with the clinical low-risk group (17% v 1%, respectively; P <0.001). Further cardiac risk stratification was evident by thallium myocardial scintigraphy. Patients with reversible thallium defects had significantly higher cardiac mortality rates than patients with no thallium defects (23% v 5%, respectively; P <0.05). Fixed thallium defects also had predictive value for cardiac mortality (29%,; P <0.05), but deaths in this fixed defect group tended to occur later in the follow-up period. The initial clinical stratification obviated the need for further noninvasive or invasive testing in nearly half of the renal transplant candidates. Thallium myocardial scintigraphy effectively identified those patients at the highest cardiac risk. In conclusion, this prospectively applied, two-tiered cardiac stratification algorithm effectively may be a cost-effective method for detecting renal transplant patients at high risk for cardiac mortality, even in long-term follow-up.

AB - In previous studies to predict future cardiac death of patients undergoing evaluation for renal transplantation, noninvasive or invasive testing of all, or nearly all, patients has been used. In an attempt to decrease the cost of cardiac risk assessment, we prospectively used a two-tiered cardiac risk assessment algorithm on 189 consecutive patients referred for renal transplant evaluation. First, patients were stratified by clinical characteristics of age ≥50 years, history of angina, insulin- dependent diabetes, congestive heart failure, or abnormal electrocardiogram (excluding left ventricular hypertrophy). Patients having none of these risk factors (n = 94) were considered at low risk for cardiac events and underwent no further cardiac evaluation. Patients with one or more of the cardiac risk factors (n = 95) were considered to be in a high-risk group and were required to undergo further evaluation with thallium myocardial scintigraphy. Follow-up of patients was for 46 ± 16 months. Cardiac mortality was significantly higher in the clinical high-risk group compared with the clinical low-risk group (17% v 1%, respectively; P <0.001). Further cardiac risk stratification was evident by thallium myocardial scintigraphy. Patients with reversible thallium defects had significantly higher cardiac mortality rates than patients with no thallium defects (23% v 5%, respectively; P <0.05). Fixed thallium defects also had predictive value for cardiac mortality (29%,; P <0.05), but deaths in this fixed defect group tended to occur later in the follow-up period. The initial clinical stratification obviated the need for further noninvasive or invasive testing in nearly half of the renal transplant candidates. Thallium myocardial scintigraphy effectively identified those patients at the highest cardiac risk. In conclusion, this prospectively applied, two-tiered cardiac stratification algorithm effectively may be a cost-effective method for detecting renal transplant patients at high risk for cardiac mortality, even in long-term follow-up.

UR - http://www.scopus.com/inward/record.url?scp=0028337209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028337209&partnerID=8YFLogxK

M3 - Article

C2 - 8023826

AN - SCOPUS:0028337209

VL - 24

SP - 65

EP - 71

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 1

ER -